Multiple Chlamydia pneumoniae antigens prime CD8+ Tc1 responses that inhibit intracellular growth of this vacuolar pathogen

Journal of Immunology

Volumn 169, Issue 5, 2002, Pages 2524-2535

  Wizel, Benjamin ^a   Starcher, Barry C ^a   Samten, Buka ^a   Chroneos, Zissis ^a   Barnes, Peter F ^a   Dzuris, John ^a   Higashimoto, Yuichiro ^a   Appella, Ettore ^a   Sette, Alessandro ^a  

^a UNIVERSITY OF TEXAS HEALTH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 4; SYNTHETIC PEPTIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; BACTERIAL GROWTH; BACTERIAL INFECTION; CHLAMYDIASIS; CHLAMYDOPHILA PNEUMONIAE; CYTOTOXIC T LYMPHOCYTE; LUNG; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN; T LYMPHOCYTE SUBPOPULATION;

EID: 0036721624     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.169.5.2524     Document Type: Article

References (66)

1. Background and current knowledge of Chlamydia pneumoniae and atherosclerosis
2. Chlamydia pneumoniae (TWAR)
3. Persistent infection with Chlamydia pneumoniae following acute respiratory illness
4. Association of Chlamydia pneumoniae (strain TWAR) infection with wheezing, asthmatic bronchitis, and adult-onset asthma
5. Chlamydia pneumoniae infection in patients with chronic obstructive pulmonary disease
6. Chlamydia pneumoniae infection of the central nervous system in multiple sclerosis
7. Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction
8. Chlamydia pneumoniae and the risk of first ischemic stroke: The Northern Manhattan Stroke Study
9. Chlamydia pneumoniae infection in circulating human monocytes is refractory to antibiotic treatment
10. + T lymphocytes specific for Mycobacterium tuberculosis
11. + T lymphocyte-mediated lysis of Chlamydia-infected L cells using an endogenous antigen pathway
12. Protective cytotoxic T lymphocytes are induced during murine infection with Chlamydia trachomatis
13. + T cells
14. + T cells in antichlamydial immunity defined by Chlamydia-specific T-lymphocyte clones
15. + T cells recognize an inclusion membrane-associated protein from the vacuolar pathogen Chlamydia trachomatis
16. + CTLs specific for the major outer membrane protein of Chlamydia trachomatis in human genital tract infections
17. A mouse model of Chlamydia pneumoniae strain TWAR pneumonitis
18. Local immune responses to Chlamydia pneumoniae in the lungs of BALB/c mice during primary infection and reinfection
19. Reactivation of Chlamydia pneumoniae lung infection in mice by cortisone
20. + cells abolishes memory in acquired immunity against Chlamydia pneumoniae in BALB/c mice
21. Role of innate and adaptive immunity in the outcome of primary infection with Chlamydia pneumoniae, as analyzed in genetically modified mice
22. Regulation and role of IFN-γ in the innate resistance to infection with Chlamydia pneumoniae
23. A sensitive cell line, HL cells, for isolation and propagation of Chlamydia pneumoniae strain TWAR
24. + TCI responses
25. Host resistance directed selectively against H-2-deficient lymphoma variants: Analysis of the mechanism
26. Differential transport requirements of HLA and H-2 class I glycoproteins
27. Further characterization of Chlamydia pneumoniae specific monoclonal antibodies
28. Chlamydia pneumoniae major outer membrane protein is a surface-exposed antigen that elicits antibodies primarily directed against conformation-dependent determinants
29. Exact prediction of a natural T cell epitope
30. The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides
31. Empty MHC class I molecules come out in the cold
32. b-restricted epitopes
33. Comparative genomes of Chlamydia pneumoniae and C. trachomatis
34. Genome sequences of Chamydia trachomatis MoPn and Chlamydia pneumoniae AR39
35. Comparison of whole genome sequences of Chlamydia pneumoniae J138 from Japan and CWL029 from USA
36. Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules
37. The relationship between class I binding affinity and Immunogenicity of potential cytotoxic T cell epitopes
38. Differences, and similarities in the A2 1-restricted cytotoxic T cell repertoire in humans and human leukocyte antigen-transgenic mice
39. The nucleotide sequence of the 60 kDa cysteine rich outer membrane protein of Chlamydia pneumoniae strain IOL-207
40. Isolation and sequence analysis of the Chlamydia pneumoniae GroE operon
41. Sequence analysis of the gene encoding the Chlamydia pneumoniae DnaK protein homolog
42. Isolation and characterization of a gene encoding a Chlamydia pneumoniae 76-kDa protein containing a species-specific epitope
43. Sequence analysis of the major outer membrane protein gene of Chlamydia pneumoniae
44. Identification of two novel genes encoding 97- to 99-kDa outer membrane proteins of Chlamydia pneumoniae
45. Inhibition of Chlamydia pneumoniae growth in HEp-2 cells pretreated with γ interferon and tumor necrosis factor α
46. Persistent chlamydiae: From cell culture to a paradigm for chlamydial pathogenesis
47. Ultrastructural study of Chlamydia pneumoniae in a continuous-infection model
48. Evidence of systemic dissemination of Chlamydia pneumoniae via macrophages in the mouse
49. Molecular characterization and outer membrane association of a Chlamydia trachomatis protein related to the hsp70 family of proteins
50. Characterization of Chlamydia pneumoniae species-specific proteins immunodominant in humans
51. Serological response to Chlamydia pneumoniae in adults with coronary arterial fatty streaks and fibrolipid plaques
52. Replication of Chlamydia pneumoniae in vitro in human macrophages, endothelial cells, and aortic artery smooth muscle cells
53. Infection and activation of airway epithelial cells by Chlamydia pneumoniae
54. MHC class I-restricted CTL responses to exogenous antigens
55. Concanamycin A, a powerful tool for characterization and estimation of contribution of perforin- and Fas-based lytic pathways in cell-mediated cytotoxicity
56. Characterization and intra-cellular trafficking pattern of vacuoles containing Chlamydia pneumoniae in human epithelial cells
57. Sphingomyelin trafficking in Chlamydia pneumoniae-infected cells
58. Type III secretion genes identify a putative virulence locus of Chlamydia
59. Chlamydia psittaci IncA is phosphorylated by the host cell and is exposed on the cytoplasmic face of the developing inclusion
60. Identification and characterization of a Chlamydia trachomatis early operon encoding four novel inclusion membrane proteins
61. A secondary structure motif predictive of protein localization to the chlamydial inclusion membrane
62. γ interferon production by cytotoxic T lymphocytes is required for resolution of Chlamydia trachomatis infection
63. Identification and characterization of protective T cells in hsp65 DNA-vaccinated and Mycobacterium tuberculosis-infected mice
64. + T cells
65. HIV suppression by interleukin-16
66. An antimicrobial activity of cytolytic T cells mediated by granulysin